Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
Metrics to compare | BIOWKS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOWKSPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.7x | −8.5x | −0.7x | |
PEG Ratio | −0.09 | −0.10 | 0.00 | |
Price/Book | 6.5x | 1.3x | 2.6x | |
Price / LTM Sales | 5.7x | 7.5x | 3.4x | |
Upside (Analyst Target) | - | 0.0% | 39.1% | |
Fair Value Upside | Unlock | 7.2% | 5.3% | Unlock |